Erythropoiesis-Stimulating Agent (ESA)
AKB-6548-CI-0052
Phase 3 small_molecule active
Quick answer
Erythropoiesis-Stimulating Agent (ESA) for Anemia of Chronic Kidney Disease is a Phase 3 program (small_molecule) at Akebia Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Akebia Therapeutics
- Indication
- Anemia of Chronic Kidney Disease
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active